CRISPR:

Kexin Xiong1, Xiaxia Wang1, Caicai Feng1

  • 1School of Pharmaceutical Sciences, Zhengzhou University, Henan Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou, 450001, China.

Advanced biology
|February 14, 2025
PubMed
概括

基因编辑CRISPR为神经疾病提供了一个有前途的治疗方法. 超出腺相关病毒 (AAV) 的新传递系统对于安全有效的体内基因组编辑疗法至关重要.